Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. To consider and approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Choksi Laboratories has informed the BSE that its Board of Directors will meet on Friday, 14 November 2025 at 3:00 PM at the registered office in Indore. The main item on the agenda is to consider and approve the Unaudited Financial Results of the company for the quarter and half year ended 30 September 2025 (Q2 FY26). The notice also has a routine 'any other item with the Chairman's permission' clause. Additionally, the company confirmed that the trading window for insiders remains closed and will reopen 48 hours after the Q2 results are announced.
No direct impact on shareholders at this stage — this is a procedural intimation ahead of the Q2 FY26 earnings release on 14 November. Investors should watch for the results declaration, which may move the stock depending on performance versus expectations.